Total Payments
$128,748
2024 Payments
$11,267
Companies
44
Transactions
558
Medicare Patients
5,904
Medicare Billing
$430,119
Payment Breakdown by Category
Other$100,702 (78.2%)
Food & Beverage$13,535 (10.5%)
Travel$9,471 (7.4%)
Consulting$4,584 (3.6%)
Education$456.97 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,685 | 45 | 78.2% |
| Food and Beverage | $13,535 | 484 | 10.5% |
| Travel and Lodging | $9,471 | 12 | 7.4% |
| Consulting Fee | $4,584 | 4 | 3.6% |
| Education | $456.97 | 12 | 0.4% |
| Debt forgiveness | $16.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $69,422 | 121 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $24,672 | 26 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $21,040 | 66 | $0 (2024) |
| Abbott Laboratories | $8,646 | 98 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $776.22 | 50 | $0 (2024) |
| Medtronic Vascular, Inc. | $687.95 | 22 | $0 (2020) |
| Amgen Inc. | $515.93 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $365.56 | 21 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $360.66 | 10 | $0 (2024) |
| PFIZER INC. | $234.10 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,267 | 63 | Actelion Pharmaceuticals US, Inc. ($9,335) |
| 2023 | $1,029 | 41 | Actelion Pharmaceuticals US, Inc. ($389.74) |
| 2022 | $1,070 | 29 | Abbott Laboratories ($585.74) |
| 2021 | $741.47 | 29 | Abbott Laboratories ($339.01) |
| 2020 | $777.79 | 21 | Abbott Laboratories ($234.58) |
| 2019 | $18,983 | 70 | Novartis Pharmaceuticals Corporation ($14,662) |
| 2018 | $33,128 | 124 | Novartis Pharmaceuticals Corporation ($27,187) |
| 2017 | $61,752 | 181 | Novartis Pharmaceuticals Corporation ($27,377) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $840.00 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $83.17 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $121.69 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Genetic Disease | ||||||
| 10/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $420.00 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $88.99 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiology | ||||||
| 08/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,460 | 1,918 | $331,599 | $107,911 |
| 2022 | 13 | 1,379 | 1,672 | $272,691 | $97,042 |
| 2021 | 15 | 1,462 | 1,905 | $298,482 | $110,870 |
| 2020 | 16 | 1,603 | 2,054 | $376,782 | $114,296 |
Total Patients
5,904
Total Services
7,549
Medicare Billing
$430,119
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 539 | $111,106 | $46,313 | 41.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 166 | 174 | $98,484 | $22,570 | 22.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 64 | $21,526 | $8,426 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $16,651 | $6,899 | 41.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 116 | $13,932 | $6,766 | 48.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 326 | 457 | $24,678 | $4,572 | 18.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 69 | 71 | $10,224 | $3,559 | 34.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 17 | 17 | $9,350 | $2,708 | 29.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 263 | 287 | $6,027 | $1,642 | 27.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 14 | $2,408 | $1,276 | 53.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 15 | 15 | $5,265 | $1,211 | 23.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $2,748 | $1,026 | 37.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 38 | $5,700 | $501.12 | 8.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $2,265 | $201.45 | 8.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $741.00 | $128.24 | 17.3% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 12 | 12 | $396.00 | $79.72 | 20.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 14 | 14 | $98.00 | $32.62 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 334 | 500 | $103,030 | $43,134 | 41.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 103 | 105 | $59,029 | $14,736 | 25.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 60 | $20,160 | $8,642 | 42.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 72 | $12,383 | $5,488 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $12,314 | $5,189 | 42.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 87 | 87 | $12,528 | $4,451 | 35.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 75 | $9,006 | $3,821 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 22 | 26 | $6,266 | $3,012 | 48.1% |
About Dr. David Moll, MD
Dr. David Moll, MD is a Cardiovascular Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780846717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Moll, MD has received a total of $128,748 in payments from pharmaceutical and medical device companies, with $11,267 received in 2024. These payments were reported across 558 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,685).
As a Medicare-enrolled provider, Moll has provided services to 5,904 Medicare beneficiaries, totaling 7,549 services with total Medicare billing of $430,119. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Student in an Organized Health Care Education/Training Program, Advanced Heart Failure and Transplant Cardiology
- Location Baton Rouge, LA
- Active Since 07/01/2008
- Last Updated 04/28/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780846717
Products in Payments
- ENTRESTO (Drug) $69,386
- Adempas (Drug) $24,507
- UPTRAVI (Drug) $9,642
- CardioMEMS HF System (Device) $5,664
- Quadra Assura CRT Defibrillator (Device) $1,053
- XARELTO (Drug) $753.96
- CRT-Ds (Device) $524.69
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $512.84
- Amplia MRI (Device) $407.24
- ONPATTRO (Drug) $360.66
- Confirm Rx (Device) $342.50
- Corlanor (Drug) $322.56
- OPSUMIT (Drug) $311.03
- VERQUVO (Drug) $233.89
- OPSUMIT MACITENTAN (Drug) $221.61
- Impella (Device) $199.80
- ELIQUIS (Drug) $191.96
- Repatha (Biological) $186.03
- Advisa (Device) $176.18
- Kerendia (Drug) $165.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Baton Rouge
Denzil Moraes, M.d, M.D
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
George Karam, Md, MD
Cardiovascular Disease — Payments: $321,210
Cardiovascular Disease $321,210
Mark Pollet, Md, MD
Cardiovascular Disease — Payments: $116,274
Cardiovascular Disease $116,274
Dr. Tara Jarreau, M.d, M.D
Cardiovascular Disease — Payments: $111,344
Cardiovascular Disease $111,344
Venkata Satish Gadi, M.d, M.D
Cardiovascular Disease — Payments: $105,858
Cardiovascular Disease $105,858
Steven Kelley, Md, MD
Cardiovascular Disease — Payments: $82,130
Cardiovascular Disease $82,130